Rationale, Design, and Interim Observations of the Steady Movement With Innovating Leadership for Heart Failure (SMILE HF) Registry: A Multicenter Prospective Cohort Registry for Patients With Acute Heart Failure-Reference-Cited by-同舟云学术

Rationale, Design, and Interim Observations of the Steady Movement With Innovating Leadership for Heart Failure (SMILE HF) Registry: A Multicenter Prospective Cohort Registry for Patients With Acute Heart Failure

Published:2024 Issue:3 Volume:6 Page:129
ISSN:2636-154X
Container-title:International Journal of Heart Failure
language:en
Short-container-title:Int J Heart Fail

Author:

Choi Jah Yeon¹^ORCID,Kim Mi-Na²^ORCID,Han Seongwoo³^ORCID,Lee Sunki¹^ORCID,Park Myung Soo³^ORCID,Kong Min Gyu⁴^ORCID,Kim Sung-Hea⁵^ORCID,Kim Yong-Hyun⁶^ORCID,Jo Sang-Ho⁷^ORCID,Kim Sungeun⁸^ORCID,Choi Seonghoon⁹^ORCID,Jeon Jinsung¹^ORCID,Lee Jieun¹^ORCID,Battumur Byambakhand¹^ORCID,Park Seong-Mi²^ORCID,Kim Eung Ju¹^ORCID,

Affiliation:

1. Department of Cardiology, Korea University Guro Hospital, Seoul, Korea.

2. Department of Cardiology, Korea University Anam Hospital, Seoul, Korea.

3. Department of Cardiology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.

4. Department of Cardiology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

5. Department of Cardiology, Konkuk University Hospital, Seoul, Korea.

6. Department of Cardiology, Korea University Ansan Hospital, Ansan, Korea.

7. Department of Cardiology, Hallym University Sacred Heart Hospital, Anyang, Korea.

8. Department of Cardiology, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea.

9. Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.

Funder

Yuhan

Hanmi Pharmaceutical

Publisher

XMLink

Link

https://e-heartfailure.org/pdf/10.36628/ijhf.2024.0014

Reference26 articles.

1. Epidemiology of Heart Failure in Korea: Present and Future

2. Update on heart failure management and future directions

3. The incremental economic burden of heart failure: A population-based investigation from South Korea

4. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials

5. Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure